A Retrospective Study of Clinical and Histopathological Features of 81 Cases of Canine Apocrine Gland Adenocarcinoma of the Anal Sac: Independent Clinical and Histopathological Risk Factors Associated with Outcome

Simple Summary: Dogs can be affected by a tumour arising from the glands of the anal sacs. These tumours can grow aggressively and spread to other organs, resulting in disruption of bowel movements and/or organ function, ultimately leading to death or euthanasia. The reason why some tumours grow or spread more quickly is not well understood, and veterinarians are not able to distinguish between dogs likely to have better or worse survival times at the time of initial diagnosis. This study evaluates clinical, imaging, and tumour features of dogs with anal sac tumours and examines which features were linked to improved survival times. Smaller tumour size, smaller lymph node size, surgical removal, and treatment with radiotherapy were associated with better survival times. When examining the tumour tissue, the presence of closely packed tumour cells, dead tumour tissue, and invasion of vessels by tumour cells were each associated with worse survival times. Features that impacted survival were used to create two checklists that, when applied to an individual case, may indicate prognosis and therefore help clinicians and owners make more informed clinical decisions.Canine apocrine gland anal sac adenocarcinoma (AGASAC) is a malignant tumour with variable clinical progression. The objective of this study was to use robust multivariate models, based on models employed in human medical oncology, to establish clinical and histopathological risk factors of poor survival. Clinical data and imaging of 81 cases with AGASAC were reviewed. Tissue was available for histological review and immunohistochemistry in 49 cases. Tumour and lymph node size were determined using the response evaluation criteria in the solid tumours system (RECIST). Modelling revealed tumour size over 2 cm, lymph node size grouped in three tiers by the two thresholds 1.6 cm and 5 cm, surgical management, and radiotherapy were independent clinical variables associated with survival, irrespective of tumour stage. Tumour size over 1.3 cm and presence of distant metastasis were independent clinical variables associated with the first progression-free interval. The presence of the histopathological variables of tumour necrosis, a solid histological pattern, and vascular invasion in the primary tumour were independent risk factors of poor survival. Based upon these independent risk factors, scoring algorithms to predict survival in AGASAC patients are presented.